Analyst ratings can significantly influence investor sentiment and stock prices. A downgrade from Overweight to Equal-Weight often implies that the analyst sees less upside potential or increased risk in the stock. This could lead to a negative short-term impact on MorphoSys's stock price as investors adjust their expectations.